The brief
- Backed by Eric Schmidt at launch in 2023.
- Its Robin agents suggested ripasudil as a possible treatment for dry macular degeneration, an eye disease (May 2025).
- Spun out Edison Scientific to sell the Kosmos AI scientist (November 2025).
Programs
FutureHouse, one program
Updated 16d agoResearch · Proto · Pilot · Deploy · Scaling
Company & funding
- HQ
- US
- Founded
- 2023
People
- Sam RodriquesCo-founder and CEO
- Andrew WhiteCo-founder

